Biotech Stocks Finally Rose in June. What Does It Mean?
The SPDR S&P Biotech ETF (ticker: XBI), which tracks small- and mid-cap biotech stocks, fell 33.7% in the first half of the year, which ended on Thursday. That’s far worse than the S&P 500, SPX –0.88% ...